ASSURE Wearable ECG vs DeepRhythmAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

ASSURE Wearable ECG

by Kestra Medical Technologies

DeepRhythmAI

by Medicalgorithmics

AI Verdict

Tool A provides a comprehensive wearable system for continuous ECG monitoring and remote patient data management, emphasizing data collection and patient oversight. Tool B, conversely, is a cloud-based, device-agnostic AI algorithm focused on highly accurate and efficient cardiac arrhythmia detection and classification from various ECG data sources. While both leverage AI for cardiac care, Tool A's primary function is continuous monitoring and data generation, whereas Tool B specializes in advanced diagnostic analysis of existing ECG data.

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if your primary need is continuous, long-term remote monitoring of at-risk cardiac patients, requiring a dedicated wearable device for real-time data collection and immediate alert-based notifications. This tool is ideal for managing patients outside of a clinical setting, providing clinicians with physiological trend data and automatic episode storage through an integrated digital platform.

View ASSURE Wearable ECG →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your focus is on significantly improving the accuracy and efficiency of cardiac arrhythmia detection and classification from existing or newly acquired ECG data. This cloud-based AI algorithm is best suited for healthcare providers seeking to streamline their ECG reporting workflows, reduce missed diagnoses across various ECG devices, and enhance the diagnostic capabilities of their cardiology practice.

View DeepRhythmAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	ASSURE Wearable ECG	DeepRhythmAI
Pricing	Contact for pricing.	Contact vendor for pricing information
Deployment	Wearable device, mobile application, and cloud-based remote patient data platform.	Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	ASSURE Wearable ECG	DeepRhythmAI
Name	ASSURE Wearable ECG	DeepRhythmAI
Company	Kestra Medical Technologies	Medicalgorithmics S.A.
Primary Function	Continuous heart rate monitoring with SensorFit Garment and ASSURE Detection Algorithm.	AI-powered arrhythmia detection and classification utilizing CNN and Transformer models.
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Clinical Decision Support & Reference
Specialties	Cardiology	Cardiology
Mobile Application	Included as part of deployment	none

Videos

Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and DeepRhythmAI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Does this tool include a device for collecting ECG data, or does it primarily analyze data from other sources?

The ASSURE Wearable ECG is a non-therapeutic device that includes a wearable ECG device for continuous heart rate monitoring and data collection. DeepRhythmAI is a cloud-based AI algorithm that analyzes cardiac arrhythmia from ECG data, and it is device-agnostic, meaning it integrates with various existing ECG devices.

How does each tool integrate into my current clinical workflow and existing systems?

The ASSURE Wearable ECG system includes a wearable device, a mobile application, and the Kestra CareStation remote patient data platform for clinician review. DeepRhythmAI is a cloud-based software with an API available, designed to integrate with various ECG devices and streamline clinical workflows for faster ECG reporting and analysis.

What are the primary clinical benefits each tool offers for cardiac arrhythmia detection and patient management?

The ASSURE Wearable ECG provides continuous heart rate monitoring, automatic episode storage, alert-based notifications, and physiologic trend data for at-risk cardiac patients. DeepRhythmAI offers AI-powered arrhythmia detection and classification with superior accuracy, aiming to reduce missed diagnoses and increase efficiency in ECG reporting and analysis.

What is the role of artificial intelligence in each of these tools?

The ASSURE Wearable ECG utilizes an ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligence for filtering motion artifacts. DeepRhythmAI is an AI algorithm that employs CNN and Transformer models, trained on over 250 billion annotated heartbeats, for advanced arrhythmia detection and classification.

What are the regulatory clearances and compliance details for each tool?

Both the ASSURE Wearable ECG and DeepRhythmAI are FDA cleared. The ASSURE Wearable ECG is also explicitly stated to be HIPAA compliant and has a Business Associate Agreement (BAA).

Is the solution focused on real-time continuous monitoring or retrospective analysis of ECG data?

The ASSURE Wearable ECG is designed for continuous heart rate monitoring and data collection from patients, providing real-time insights and alerts. DeepRhythmAI focuses on the analysis of existing ECG data, offering advanced detection and classification of arrhythmias from recordings already obtained by other devices.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring ASSURE Wearable ECG or DeepRhythmAI

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

Longitude Capital